Tianjin Ringpu Bio Tech Net Assets

Latest as of March 2026: CN¥5.27 Billion CNY ≈ $771.41 Million USD

Tianjin Ringpu Bio Tech net assets. Based on the latest financial reports, Tianjin Ringpu Bio Tech (300119) has net assets worth CN¥5.27 Billion CNY (≈ $771.41 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥7.80 Billion ≈ $1.14 Billion USD) and total liabilities (CN¥2.53 Billion ≈ $370.32 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset momentum of Tianjin Ringpu Bio Tech to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥5.27 Billion
% of Total Assets	67.57%
Annual Growth Rate	22.41%
5-Year Change	19.91%
10-Year Change	146.25%
Growth Volatility	105.6

Net Assets of Tianjin Ringpu Bio Tech (2007–2025)

Net assets of Tianjin Ringpu Bio Tech from 2007 to 2025. This chart illustrates how Tianjin Ringpu Bio Tech's net assets have evolved over time, based on quarterly financial data. See Tianjin Ringpu Bio Tech net asset quality index to measure how much of total assets are equity-financed.

Annual Net Assets for Tianjin Ringpu Bio Tech (2007–2025)

The table below shows the annual net assets of Tianjin Ringpu Bio Tech from 2007 to 2025. For live market cap and overall valuation, see 300119 market cap.

Year	Net Assets	Change
2025-12-31	CN¥5.18 Billion ≈ $758.67 Million	+3.55%
2024-12-31	CN¥5.01 Billion ≈ $732.68 Million	+4.21%
2023-12-31	CN¥4.80 Billion ≈ $703.11 Million	+6.75%
2022-12-31	CN¥4.50 Billion ≈ $658.65 Million	+4.10%
2021-12-31	CN¥4.32 Billion ≈ $632.69 Million	+57.97%
2020-12-31	CN¥2.74 Billion ≈ $400.51 Million	+16.12%
2019-12-31	CN¥2.36 Billion ≈ $344.92 Million	+4.56%
2018-12-31	CN¥2.25 Billion ≈ $329.89 Million	+3.59%
2017-12-31	CN¥2.18 Billion ≈ $318.46 Million	+3.36%
2016-12-31	CN¥2.11 Billion ≈ $308.09 Million	+19.03%
2015-12-31	CN¥1.77 Billion ≈ $258.84 Million	+2.50%
2014-12-31	CN¥1.73 Billion ≈ $252.53 Million	+0.32%
2013-12-31	CN¥1.72 Billion ≈ $251.73 Million	+8.44%
2012-12-31	CN¥1.59 Billion ≈ $232.13 Million	+6.03%
2011-12-31	CN¥1.50 Billion ≈ $218.92 Million	+4.86%
2010-12-31	CN¥1.43 Billion ≈ $208.78 Million	+465.11%
2009-12-31	CN¥252.48 Million ≈ $36.95 Million	+1.00%
2008-12-31	CN¥249.97 Million ≈ $36.58 Million	+83.53%
2007-12-31	CN¥136.21 Million ≈ $19.93 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Tianjin Ringpu Bio Tech's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 4772.6% over the analyzed period, indicating profitable operations and earnings retention.

Tianjin Ringpu Bio Tech Net Assets Breakdown (December 2025)

Tianjin Ringpu Bio Tech net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Retained Earnings	CN¥2.05 Billion	43.63%
Other Components	CN¥2.65 Billion	56.37%
Total Equity	CN¥4.70 Billion	100.00%

Tianjin Ringpu Bio Tech Competitors by Market Cap

The table below lists competitors of Tianjin Ringpu Bio Tech ranked by their market capitalization.

Company	Market Cap
Luoyang Longhua Heat Trans Energy SHE:300263	$1.15 Billion
Hunan Valin Wire & Cable Co Ltd SHE:001208	$1.15 Billion
OMH SCIENCE Group Co Ltd SHE:300486	$1.15 Billion
Flow Traders BV AS:FLOW	$1.15 Billion
Lotte Corp KO:004990	$1.15 Billion
Yunnan Hongxiang Yixintang SHE:002727	$1.15 Billion
Shinkong Synthetic Fiber Corp TW:1409	$1.15 Billion
Shaanxi Provincial Natural Gas Co Ltd SHE:002267	$1.15 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Tianjin Ringpu Bio Tech's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 4,469,990,178 to 4,703,083,000, a change of 233,092,822 (5.2%).
Net income of 400,513,484 contributed positively to equity growth.
Dividend payments of 167,496,074 reduced retained earnings.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥400.51 Million	+8.52%
Dividends Paid	CN¥167.50 Million	-3.56%
Other Changes	CN¥75.41K	+0.0%
Total Change	CN¥-	5.21%

Book Value vs Market Value Analysis

This analysis compares Tianjin Ringpu Bio Tech's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.67x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 38.81x to 1.67x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2007-12-31	CN¥0.44	CN¥16.90	x
2008-12-31	CN¥0.72	CN¥16.90	x
2009-12-31	CN¥0.71	CN¥16.90	x
2010-12-31	CN¥4.36	CN¥16.90	x
2011-12-31	CN¥3.61	CN¥16.90	x
2012-12-31	CN¥3.88	CN¥16.90	x
2013-12-31	CN¥4.17	CN¥16.90	x
2014-12-31	CN¥4.19	CN¥16.90	x
2015-12-31	CN¥4.13	CN¥16.90	x
2016-12-31	CN¥4.83	CN¥16.90	x
2017-12-31	CN¥4.82	CN¥16.90	x
2018-12-31	CN¥4.97	CN¥16.90	x
2019-12-31	CN¥5.34	CN¥16.90	x
2020-12-31	CN¥6.20	CN¥16.90	x
2021-12-31	CN¥10.02	CN¥16.90	x
2022-12-31	CN¥9.12	CN¥16.90	x
2023-12-31	CN¥9.70	CN¥16.90	x
2024-12-31	CN¥9.71	CN¥16.90	x
2025-12-31	CN¥10.12	CN¥16.90	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Tianjin Ringpu Bio Tech utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 8.52%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 11.79%
• Asset Turnover: 0.44x
• Equity Multiplier: 1.63x
Recent ROE (8.52%) is below the historical average (11.49%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2007	37.21%	25.30%	0.78x	1.88x	CN¥27.03 Million
2008	21.96%	19.33%	0.67x	1.70x	CN¥23.60 Million
2009	29.80%	21.55%	0.69x	2.01x	CN¥40.86 Million
2010	6.10%	23.88%	0.21x	1.20x	CN¥-52.77 Million
2011	8.19%	19.41%	0.35x	1.20x	CN¥-25.20 Million
2012	9.71%	21.95%	0.37x	1.21x	CN¥-4.35 Million
2013	9.43%	20.13%	0.38x	1.24x	CN¥-9.18 Million
2014	1.67%	4.61%	0.30x	1.23x	CN¥-134.50 Million
2015	6.86%	13.91%	0.34x	1.46x	CN¥-50.46 Million
2016	6.98%	13.69%	0.35x	1.44x	CN¥-57.57 Million
2017	5.37%	10.02%	0.36x	1.50x	CN¥-90.29 Million
2018	5.92%	10.00%	0.40x	1.49x	CN¥-82.04 Million
2019	9.16%	13.25%	0.41x	1.68x	CN¥-17.83 Million
2020	16.22%	19.91%	0.51x	1.59x	CN¥152.64 Million
2021	10.24%	20.57%	0.35x	1.41x	CN¥9.52 Million
2022	8.21%	16.63%	0.34x	1.45x	CN¥-75.45 Million
2023	10.09%	16.74%	0.41x	1.47x	CN¥3.96 Million
2024	6.73%	9.80%	0.39x	1.78x	CN¥-146.28 Million
2025	8.52%	11.79%	0.44x	1.63x	CN¥-69.79 Million

Industry Comparison

This section compares Tianjin Ringpu Bio Tech's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $2,124,889,896
Average return on equity (ROE) among peers: 7.89%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Tianjin Ringpu Bio Tech (300119)	CN¥5.27 Billion	37.21%	0.48x	$1.15 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078)	$902.62 Million	5.17%	3.60x	$492.82 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153)	$1.56 Billion	7.90%	1.45x	$363.79 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423)	$366.91 Million	9.97%	0.26x	$4.71 Billion
Livzon Pharmaceutical Group Inc (000513)	$14.91 Billion	13.83%	0.64x	$2.63 Billion
Wedge Industrial Co Ltd (000534)	$654.70 Million	1.92%	0.87x	$1.28 Billion
Yunnan Baiyao Group Co Ltd (000538)	$35.11 Million	18.13%	0.80x	$14.36 Billion
Hainan Haiyao Co Ltd (000566)	$317.39 Million	7.74%	0.74x	$766.98 Million
Tus Pharmaceutical Group Co Ltd (000590)	$268.54 Million	1.60%	1.47x	$273.68 Million
Northeast Pharmaceutical Group Co Ltd (000597)	$889.22 Million	5.34%	2.43x	$935.44 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623)	$1.35 Billion	7.34%	0.44x	$3.04 Billion

About Tianjin Ringpu Bio Tech

SHE:300119 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.15 Billion

CN¥7.85 Billion CNY

Market Cap Rank

#8077 Global

#1792 in China

Share Price

CN¥16.90

Change (1 day)

-0.06%

52-Week Range

CN¥14.38 - CN¥21.44

All Time High

CN¥39.94